Literature DB >> 8057440

Lack of correlation between basal expression levels and susceptibility to transcriptional shutdown among single-gene murine leukemia virus vector proviruses.

M Duch1, K Paludan, P Jørgensen, F S Pedersen.   

Abstract

Integrated retroviruses or retroviral vectors may be transcriptionally inactive although their promoter-enhancer regions are able to direct transcription in the host cell. We have used single-gene retroviral vectors with a long terminal repeat-directed neo marker gene to determine if the level of transcription relates to the susceptibility of a provirus to inactivation. We used two isogenic vectors, carrying long terminal repeats with a strong and a weak transcriptional enhancer derived from SL3-3 and Akv murine leukemia viruses, respectively. Nonselected cell clones of the murine lymphoid cell line L691 with single integrated vector proviruses exhibiting a 20-fold range of initial expression levels were studied. The basal expression level of a given cell clone with a single provirus did not show any pattern of correlation with the long-term stability of expression, as monitored for periods up to 150 days. Our results thus indicate that the inactivation mechanism operates independently of the initial transcriptional activity of the provirus.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8057440      PMCID: PMC236960     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

1.  Quantitative analysis of gene suppression in integrated retrovirus vectors.

Authors:  M Emerman; H M Temin
Journal:  Mol Cell Biol       Date:  1986-03       Impact factor: 4.272

2.  Chromosomal position or virus mutation permits retrovirus expression in embryonal carcinoma cells.

Authors:  E Barklis; R C Mulligan; R Jaenisch
Journal:  Cell       Date:  1986-11-07       Impact factor: 41.582

3.  The role of MuLV receptors on T-lymphoma cells in lymphoma cell proliferation.

Authors:  M S McGrath; E Pillemer; D Kooistra; I L Weissman
Journal:  Contemp Top Immunobiol       Date:  1980

4.  A correlation between dexamethasone inducibility and basal expression levels of retroviral vector proviruses.

Authors:  M Duch; K Paludan; J Lovmand; L Pedersen; P Jørgensen; F S Pedersen
Journal:  Nucleic Acids Res       Date:  1993-10-11       Impact factor: 16.971

5.  Genes with promoters in retrovirus vectors can be independently suppressed by an epigenetic mechanism.

Authors:  M Emerman; H M Temin
Journal:  Cell       Date:  1984-12       Impact factor: 41.582

6.  Glucocorticoids and chromosomal position modulate murine mammary tumor virus transcription by affecting efficiency of promoter utilization.

Authors:  D S Ucker; G L Firestone; K R Yamamoto
Journal:  Mol Cell Biol       Date:  1983-04       Impact factor: 4.272

7.  Varied interactions between proviruses and adjacent host chromatin.

Authors:  K F Conklin; M Groudine
Journal:  Mol Cell Biol       Date:  1986-11       Impact factor: 4.272

8.  Determination of the leukaemogenicity of a murine retrovirus by sequences within the long terminal repeat.

Authors:  J Lenz; D Celander; R L Crowther; R Patarca; D W Perkins; W A Haseltine
Journal:  Nature       Date:  1984 Mar 29-Apr 4       Impact factor: 49.962

9.  Chromosomal position and specific demethylation in enhancer sequences of germ line-transmitted retroviral genomes during mouse development.

Authors:  D Jähner; R Jaenisch
Journal:  Mol Cell Biol       Date:  1985-09       Impact factor: 4.272

10.  The chromosomal integration site determines the tissue-specific methylation of mouse mammary tumour virus proviral genes.

Authors:  W H Günzburg; B Groner
Journal:  EMBO J       Date:  1984-05       Impact factor: 11.598

View more
  9 in total

1.  Increased lymphomagenicity and restored disease specificity of AML1 site (core) mutant SL3-3 murine leukemia virus by a second-site enhancer variant evolved in vivo.

Authors:  S Ethelberg; J Lovmand; J Schmidt; A Luz; F S Pedersen
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

Review 2.  Biomaterial strategies for stem cell maintenance during in vitro expansion.

Authors:  Xiang-Zhen Yan; Jeroen J J P van den Beucken; Sanne K Both; Pi-Shan Yang; John A Jansen; Fang Yang
Journal:  Tissue Eng Part B Rev       Date:  2013-12-05       Impact factor: 6.389

Review 3.  Development of retroviral vectors as safe, targeted gene delivery systems.

Authors:  W H Günzburg; B Salmons
Journal:  J Mol Med (Berl)       Date:  1996-04       Impact factor: 4.599

4.  Human beta interferon scaffold attachment region inhibits de novo methylation and confers long-term, copy number-dependent expression to a retroviral vector.

Authors:  Q Dang; J Auten; I Plavec
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

5.  Novel retroviral vector transferring a suicide gene and a selectable marker gene with enhanced gene expression by using a tetracycline-responsive expression system.

Authors:  J J Hwang; Z Scuric; W F Anderson
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

6.  Murine leukemia virus-based Tat-inducible long terminal repeat replacement vectors: a new system for anti-human immunodeficiency virus gene therapy.

Authors:  P M Cannon; N Kim; S M Kingsman; A J Kingsman
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

Review 7.  Amplified and tissue-directed expression of retroviral vectors using ping-pong techniques.

Authors:  M E Hoatlin; S L Kozak; C Spiro; D Kabat
Journal:  J Mol Med (Berl)       Date:  1995-03       Impact factor: 4.599

8.  Second-site proviral enhancer alterations in lymphomas induced by enhancer mutants of SL3-3 murine leukemia virus: negative effect of nuclear factor 1 binding site.

Authors:  S Ethelberg; B Hallberg; J Lovmand; J Schmidt; A Luz; T Grundström; F S Pedersen
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

9.  In vivo rescue of a silent tax-deficient bovine leukemia virus from a tumor-derived ovine B-cell line by recombination with a retrovirally transduced wild-type tax gene.

Authors:  A Van Den Broeke; C Bagnis; M Ciesiolka; Y Cleuter; H Gelderblom; P Kerkhofs; P Griebel; P Mannoni; A Burny
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.